Belgium holds a leading position in the European (bio)pharmaceutical sector. Among all countries of the European Union, Belgium has the highest level of pharmaceutical investments in research and development per inhabitant. Together with the third position in pharmaceutical R&D employment per inhabitant, Belgium is a gem in (bio)pharmaceutical innovation within the European Union. This presentation, will illustrate the vitality of our sector dedicated to patients in Belgium, Europe and the world. Moreover, the presenters will show how the digitalization and the use of data is impacting the pharmaceutical industry.